tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of James Shin, 23 are a BUY (45.1%), 28 are a HOLD (54.9%).
Analyst James Shin, currently employed at DEUTSCHE BANK, carries an average stock price target met ratio of 76.15% that have a potential upside of 23.62% achieved within 198 days.
James Shin’s has documented 102 price targets and ratings displayed on 12 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on GILD, Gilead Sciences at 27-Mar-2026.
Analyst best performing recommendations are on IMGN (IMMUNOGEN).
The best stock recommendation documented was for BMY (BRISTOL-MYERS SQUIBB COMPANY) at 7/23/2024. The price target of $45 was fulfilled within 3 days with a profit of $5.83 (14.88%) receiving and performance score of 49.61.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 20-Feb-2026
$325
$39.36 (13.78%)
$300
Buy Since 05-Feb-2020
$288
$2.36 (0.83%)
$288
16 days ago
(09-Oct-2026)
45/45 (100%)
$11.53 (4.17%)
407
Hold Since 07-Jan-2026
$275
$-10.64 (-3.72%)
$260
16 days ago
(09-Oct-2026)
5/5 (100%)
$-1.47 (-0.53%)
76
Buy Since 16-Oct-2020
$300
$14.36 (5.03%)
$280
17 days ago
(08-Oct-2026)
20/21 (95.24%)
$27.58 (10.12%)
441
Buy Since 16-Nov-2023
$290
$4.36 (1.53%)
$285
17 days ago
(08-Oct-2026)
31/32 (96.88%)
$17.58 (6.45%)
251
What Year was the first public recommendation made by James Shin?
